Zobrazeno 1 - 9
of 9
pro vyhledávání: '"NETs, neuroendocrine tumors"'
Autor:
Mika Watanabe, Hitoshi Niikura, Michiko Kaiho-Sakuma, Satomi Kameda, Masafumi Toyoshima, Nobuo Yaegashi, Takamichi Minato, Asami Toki
Publikováno v:
Gynecologic Oncology Reports
Gynecologic Oncology Reports, Vol 23, Iss C, Pp 20-23 (2018)
Gynecologic Oncology Reports, Vol 23, Iss C, Pp 20-23 (2018)
Highlights • Neuroendocrine tumors (NETs) frequently occur in the lungs or the gastrointestinal tract; they are uncommon in the ovary. • The mammalian target of rapamycin (mTOR) pathway has been reported as a treatment for advanced NETs. • We d
Autor:
Wataru Izumo, Masahiro Shiihara, Yutaro Matsunaga, Ryota Higuchi, Shuichiro Uemura, Takehisa Yazawa, Masakazu Yamamoto, Toru Furukawa
Publikováno v:
International Journal of Surgery Case Reports
Highlights • Mixed adeno-neuroendocrine carcinoma arising primarily in the bile duct is very rare neoplasm. • The patient with mixed adeno-neuroendocrine carcinoma in the bile duct indicates a poor prognosis. • On imaging studies, a hypervascul
Autor:
Fayçal Zine-Eddine, Jean-Mathieu Beauregard, Rashmi G. Shah, Samuel Adant, Girish M. Shah, Marine A. Merlin
Publikováno v:
Cancers
Volume 13
Issue 2
Cancers, Vol 13, Iss 232, p 232 (2021)
Volume 13
Issue 2
Cancers, Vol 13, Iss 232, p 232 (2021)
The peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTA-octreotate (LuTate) is recommended for different types of neuroendocrine tumors (NETs) which overexpress somatostatin receptors (SSTR). A combination with chemotherapy improves objectiv
Autor:
Makinoshima Hideki, Ishii Genichiro, Kojima Motohiro, Fujii Satoshi, Higuchi Youichi, Kuwata Takeshi, Ochiai Atsushi
Publikováno v:
BMC Cancer, Vol 12, Iss 1, p 537 (2012)
Abstract Background Small-cell lung carcinoma (SCLC) is a neuroendocrine tumor subtype and comprises approximately 15% of lung cancers. Because SCLC is still a disease with a poor prognosis and limited treatment options, there is an urgent need to de
Externí odkaz:
https://doaj.org/article/a1efc55cd7c84def879850e6328f427d
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Current medicinal chemistry. 21(8)
Advanced enteropancreatic (EP) neuroendocrine tumors (NETs) can be treated with several different therapies, including chemotherapy, biotherapy, and locoregional treatments. Over the last few decades, impressive progress has been made in the biothera
Autor:
Tang SJ; Division of Digestive Diseases, Department of Medicine, University of Mississippi Medical Center, Jackson, Mississippi.
Publikováno v:
VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy [VideoGIE] 2020 Dec 09; Vol. 6 (3), pp. 136-138. Date of Electronic Publication: 2020 Dec 09 (Print Publication: 2021).
Autor:
Kaiho-Sakuma M; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Toyoshima M; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Watanabe M; Department of Pathology, Tohoku University Hospital, Sendai, Japan., Toki A; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Kameda S; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Minato T; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Niikura H; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan., Yaegashi N; Department of Obstetrics and Gynecology, Tohoku University Hospital, Sendai, Japan.
Publikováno v:
Gynecologic oncology reports [Gynecol Oncol Rep] 2018 Jan 04; Vol. 23, pp. 20-23. Date of Electronic Publication: 2018 Jan 04 (Print Publication: 2018).